Welcome international healthcare professionals

Welcome, this website is intended for healthcare professionals with an interest in the ECC Webcasts. By clicking the button below you are declaring and confirming that you are a healthcare professional.

You are here

Sat 26 Sept / 19.00 to 20:30 / Hall A2

This webcast discusses how to build on existing targeted treatment successes for HER2+ and HR+ ABC and inform the next-generation of treatment combinations. Critical signalling pathways in HR+ ABC are reviewed, and investigational treatment combinations targeting the CDK4/6 or PI3K/mTOR pathways are explored.

This Webcast and Webcast Report were supported by Novartis Oncology, all items are subject to independent peer and editorial review.